Samantha Reiter

IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers

S. Weaver, A. Baum, C. Kyratsous, 2021, medRxiv.

Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2

E. Theel, S. Weaver, A. Baum, 2020, bioRxiv.

Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine

A. Baum, C. Kyratsous, K. Peng, 2021, bioRxiv.

Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of New York City Metro Blood Donors using Multiple SARS-CoV-2 Serological Assays: Implications for Controlling the Epidemic and Reopening.

Daniel J. Nesbitt, C. Hillyer, C. Kyratsous, 2020, medRxiv.

Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and “Reopening”

Daniel J. Nesbitt, C. Hillyer, C. Kyratsous, 2020, medRxiv.